Sanofi India Limited
NSE: SANOFI · Pharmaceuticals · sector
₹2,852.80NSE close 2026-10-26
Key numbers
Market cap₹6,561 cr
Price₹2,852.80
52w high / low₹4,898 / ₹2,820
P/E20.3xSector median 27.9x
P/B7.9xSector median 2.9x
Book value₹359.1
Dividend yield–Sector median 0.48%
ROE40.3%Sector median 11.7%
ROCE52.9%Sector median 12.3%
OPM25.2%Sector median 14.0%
Debt / equity0.00xSector median 0.16x
EV/EBITDA13.6xSector median 18.6x
Interest cover273.2x
Current ratio1.90x
Sales growth 3y–Sector median +9.6%
Profit growth 3y–Sector median +13.3%
PEG–
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 273.2x in the last 12 months.
- No promoter shares are pledged.
- Revenue was higher than a year earlier in 1 of the last 4 quarters.
- Other income was 6% of net profit in the last 12 months.
- Price ₹2,852.80 on 2026-10-26: -41.8% from the 52-week high, +1.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹7,207.40 · low ₹2,852.80
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 524 | 515 | 536 | 406 | 475 | 420 | 472 | 438 |
| EBITDA | 120 | 126 | 172 | 95 | 107 | 90 | 143 | 115 |
| OPM % | 22.8% | 24.5% | 32.1% | 23.4% | 22.5% | 21.5% | 30.2% | 26.3% |
| Other income | 2 | 6 | 3 | 9 | 5 | 3 | 4 | 6 |
| Net profit | 82 | 91 | 120 | 70 | 76 | 62 | 103 | 84 |
| EPS (₹) | 35.69 | 40.00 | 51.89 | 30.18 | 32.99 | 26.79 | 44.55 | 36.26 |
| Revenue YoY | -9.3% | -18.5% | -11.9% | +7.7% | ||||
| Profit YoY | -7.5% | -32.4% | -14.1% | +20.1% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | TTM |
|---|---|
| Revenue | 1,805 |
| EBITDA | 455 |
| Net profit | 324 |
| EPS (₹) | 140.59 |
| Dividend / share (₹) |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | -8.9% |
| Net profit | – | – | -10.7% |
| EPS | – | – | – |
| Share price | – | -35.0% (2y) | -40.8% |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 60.40% |
| FIIs | 5.73% |
| DIIs | 19.41% |
| of which Mutual funds | 8.62% |
| of which Insurance | 10.78% |
| Government | 0.00% |
| Public (non-institutions) | 14.46% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% |
| Promoter group | % |
|---|---|
| Hoechst GMBH | 45.18% |
| Sanofi Healthcare India Private Limited | 15.20% |
| Sanofi | 0.02% |
| CKW PHARMA EXTRAKT BETEILIGUNGS UND VERWALTUNGS Gm | 0.00% |
| CKW PHARMA EXTRAKT GMBH & Co.KG | 0.00% |
| Future Capital AG Hessen Life Sciences Chemie | 0.00% |
| Sanofi Aventis de Colombia S.A. | 0.00% |
| Sanofi Aventis Deutschland GmbH | 0.00% |
| Starlink Logistics Inc. (SLLI) | 0.00% |
| Aventis Agriculture | 0.00% |
| Carraig Insurance DAC | 0.00% |
| Sanofi Cathay (Shanghai) Private Equity Investment Fund Partnership (L.P.) | 0.00% |
| Innobio 2 | 0.00% |
| Le Rock Re | 0.00% |
| Limited Liability Company Sanofi Aventis Ukraine | 0.00% |
| Public holders above 1% | % |
|---|---|
| LIFE INSURANCE CORPORATION OF INDIA - P & GS Fund | 5.95% |
| Nippon Life India Trustee Ltd- A/C Nippon India Growth MID CAP Fund | 4.17% |
| General Insurance Corporation of India | 2.56% |
| Aditya Birla SUN Life Mutual Fund - Aditya Birla SUN Life Large CAP Fund | 2.04% |
| Bajaj Life Insurance Limited | 1.44% |
| SBI Contra Fund | 1.09% |
80,089 shareholders. Pledged: 0.00% of promoter shares.
Peers in Pharmaceuticals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹4,17,478 cr | 34.5x | 5.0x | 15.5% | 18.7% | 28.6% | +10.0% | 0.94% |
| DIVISLAB | ₹2,39,825 cr | 82.1x | 14.3x | 18.4% | 23.0% | 34.7% | +10.8% | 0.34% |
| TORNTPHARM | ₹1,53,999 cr | 72.7x | 18.4x | 27.3% | 15.1% | 32.3% | +13.3% | 0.84% |
| ZYDUSLIFE | ₹1,15,808 cr | 25.9x | 4.3x | 17.7% | 16.8% | 27.2% | +16.4% | 0.95% |
| LAURUSLABS | ₹1,11,232 cr | 101.6x | 21.0x | 22.4% | 20.8% | 28.0% | +4.1% | 0.08% |
| CIPLA | ₹1,09,464 cr | 32.5x | 3.2x | 10.3% | 13.2% | 17.7% | +7.4% | 1.18% |
| DRREDDY | ₹1,09,460 cr | 33.9x | 2.9x | 9.0% | 10.1% | 15.5% | +11.0% | 0.61% |
| MANKIND | ₹95,486 cr | 46.7x | 5.9x | 13.4% | 13.8% | 25.1% | +17.7% | 0.04% |
| AUROPHARMA | ₹91,489 cr | 24.9x | 2.4x | 10.5% | 12.8% | 20.0% | +10.6% | 0.26% |
| SANOFI | ₹6,561 cr | 20.3x | 7.9x | 40.3% | 52.9% | 25.2% | – | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-04-22 | Dividend | Dividend - Rs 48 Per Share |
| 2025-11-07 | Dividend | Interim Dividend - Rs 75 Per Share |
| 2025-04-25 | Dividend | Dividend - Rs 117 Per Share |
| 2024-06-13 | Restructuring | Demerger |
| 2024-05-03 | Dividend | Dividend - Rs 117 Per Share |
| 2024-05-03 | Other | Annual General Meeting |
| 2024-03-07 | Dividend | Interim Dividend - Rs 50 Per Share |
| 2023-04-28 | Dividend | Final Dividend - Rs 194/ Special Dividend - Rs 183 Per Share |
| 2022-08-05 | Dividend | Special Dividend - Rs 193 Per Sh |
| 2022-04-12 | Dividend | Annual General Meeting/Dividend - Rs 181 Per Share/Special Dividend - Rs 309 Per Share |
| 2021-04-19 | Dividend | Dividend - Rs 125 Per Share Special Dividend 240 Per Share |
| 2020-06-29 | Dividend | Dividend - Rs 106 Per Share Special Dividend 243 Per Share |
| 2019-04-25 | Dividend | Annual General Meeting / Dividend - Rs 66 Per Share |
| 2018-08-06 | Dividend | Interim Dividend -Rs 18 Per Share |
| 2018-04-26 | Dividend | Annual General Meeting/ Dividend - Rs 53 Per Share |
| 2017-07-31 | Dividend | Interim Dividend-Rs 18/- Per Share |
| 2017-04-25 | Dividend | Annual General Meeting/Dividend Rs 50/- Per Share |
| 2016-08-04 | Dividend | Interim Dividend - Rs 18/- Per Share |
| 2016-04-13 | Dividend | Final Dividend - Rs 25/- Per Share + Special Dividend - Rs 22/- Per Share |
| 2015-07-29 | Dividend | Interim Dividend - Rs 18/- Per Share (Purpose Revised) |
Documents
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Annual report FY21
- Announcements NSE filings
- BRSR FY25
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacture and trading of drugs and pharmaceutical products: Drugs and Pharmaceuticals
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Sub-industry | Pharmaceuticals |
| Symbol | SANOFI |
| BSE code | 500674 |
| ISIN | INE058A01010 |
| Face value | ₹10.0 |
| Incorporated | 1956-05-02 |
| Website | www.sanofiindialtd.com |
| Plants (India / abroad) | 1 / 0 |
From the company's filings (BRSR FY25).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.